We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPL
176
PPL Corp
PPL
$26.7B
$357K 0.04%
12,500
-600
-5% -$16.6K
PBCT
177
DELISTED
People's United Financial Inc
PBCT
$350K 0.04%
19,363
– –
APD icon
178
Air Products & Chemicals
APD
$67.6B
$348K 0.04%
2,233
– –
UHT
179
Universal Health Realty Income Trust
UHT
$594M
$345K 0.04%
5,396
– –
PRGO icon
180
Perrigo
PRGO
$1.78B
$339K 0.04%
4,645
-505
-10% -$38.9K
WEC icon
181
WEC Energy
WEC
$35.1B
$335K 0.04%
5,185
+135
+3% +$8.39K
FCX icon
182
Freeport-McMoran
FCX
$97.5B
$331K 0.03%
19,159
– –
LLL
183
DELISTED
L3 Technologies, Inc.
LLL
$327K 0.03%
1,700
-200
-11% -$39.9K
RNR icon
184
RenaissanceRe
RNR
$13.4B
$325K 0.03%
2,700
– –
RTN
185
DELISTED
Raytheon Company
RTN
$319K 0.03%
1,650
– –
WAT icon
186
Waters Corp
WAT
$39.9B
$317K 0.03%
1,637
– –
ET icon
187
Energy Transfer Partners
ET
$69.3B
$316K 0.03%
18,320
– –
VOD icon
188
Vodafone
VOD
$37.4B
$315K 0.03%
12,965
– –
TWTR
189
DELISTED
Twitter, Inc.
TWTR
$312K 0.03%
+7,150
New +$251K
HES
190
DELISTED
Hess
HES
$308K 0.03%
4,612
– –
D icon
191
Dominion Energy
D
$59.3B
$306K 0.03%
4,486
– –
SIVB
192
DELISTED
SVB Financial Group
SIVB
$289K 0.03%
+1,000
New +$294K
MRKR icon
193
Marker Therapeutics
MRKR
$18.7M
$284K 0.03%
3,010
-9,200
-75% -$469K
L icon
194
Loews
L
$23.6B
$274K 0.03%
5,670
– –
AMGN icon
195
Amgen
AMGN
$222B
$268K 0.03%
1,451
– –
CAH icon
196
Cardinal Health
CAH
$55.4B
$268K 0.03%
5,482
– –
ALB icon
197
Albemarle
ALB
$15.5B
$259K 0.03%
2,750
– –
TDG icon
198
TransDigm Group
TDG
$67.7B
$257K 0.03%
745
– –
OEF icon
199
iShares S&P 100 ETF
OEF
$20.6B
$256K 0.03%
2,140
-40
-2% -$4.76K
KEYS icon
200
Keysight
KEYS
$58.3B
$240K 0.03%
4,064
– –
6 7
8
9 10

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.